UBS and Morgan Stanley downgraded Chemours price targets, while TSS sold Opteon refrigerants.
1 report, 1 independent
Updated Oct 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS and Morgan Stanley downgraded Chemours price targets, while TSS sold Opteon refrigerants.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley reduced its price target on DT Midstream, while Scotiabank set a new price objective, as reported by Benzinga.
- Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.
- Citigroup and UBS raised their price targets for Procter & Gamble.